In the last 12 months, insiders at Theriva Biologics, Inc. ($TOVX) filed 19 transactions with the SEC: 7 open-market purchases totaling $159,974 and 0 sales totaling $0. Net insider sentiment: net buying.
Theriva Biologics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- SHALLCROSS STEVEN A (CEO and CFO) — 10 transactions totaling $159,974
- Kraws Jeffrey J (Director) — 3 transactions totaling $0
- MONAHAN JOHN J (Director) — 3 transactions totaling $0
- Wolf Jeffrey Alan (Director) — 3 transactions totaling $0
View all SEC Filings for Theriva Biologics, Inc. (TOVX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Wolf Jeffrey Alan | Director | A | Stock Options (right to buy) | 75000 | $0.00 | 75,000.0000 | 9,676,521 | 9999.99% | 0.78% |
| Jan. 5, 2026 | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 75000 | $0.00 | 75,000.0000 | 9,676,521 | 9999.99% | 0.78% |
| Jan. 5, 2026 | MONAHAN JOHN J | Director | A | Stock Options (right to buy) | 75000 | $0.00 | 75,000.0000 | 9,676,521 | 9999.99% | 0.78% |
| Jan. 5, 2026 | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 475000 | $0.00 | 475,000.0000 | 9,676,521 | 9999.99% | 4.91% |
| April 29, 2025 | Wolf Jeffrey Alan | Director | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 2,782,449 | 9999.99% | 0.90% |
| April 29, 2025 | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 190000 | $0.00 | 190,000.0000 | 2,782,449 | 9999.99% | 6.83% |
| April 29, 2025 | MONAHAN JOHN J | Director | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 2,782,449 | 9999.99% | 0.90% |
| April 29, 2025 | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 25000 | $0.00 | 25,000.0000 | 2,782,449 | 9999.99% | 0.90% |
| Dec. 14, 2023 | MONAHAN JOHN J | Director | A | Stock Options (right to buy) | 110000 | $0.00 | 110,000.0000 | 681,708 | 9999.99% | 16.14% |
| Dec. 14, 2023 | SHALLCROSS STEVEN A | CEO and CFO | A | Stock Options (right to buy) | 700000 | $0.00 | 700,000.0000 | 681,708 | 9999.99% | 100.00% |
| Dec. 14, 2023 | Wolf Jeffrey Alan | Director | A | Stock Options (right to buy) | 110000 | $0.00 | 110,000.0000 | 681,708 | 9999.99% | 16.14% |
| Dec. 14, 2023 | Kraws Jeffrey J | Director | A | Stock Options (right to buy) | 110000 | $0.00 | 110,000.0000 | 681,708 | 9999.99% | 16.14% |
| June 7, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 14000 | $0.69 | 250,000.0000 | 15,124,061 | 5.93% | 0.09% |
| June 6, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 26000 | $0.63 | 236,000.0000 | 15,124,061 | 12.38% | 0.17% |
| Feb. 10, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $1.04 | 210,000.0000 | 15,327,328 | 13.51% | 0.16% |
| Feb. 2, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.94 | 185,000.0000 | 15,327,328 | 15.63% | 0.16% |
| Jan. 25, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.87 | 160,000.0000 | 15,327,328 | 18.52% | 0.16% |
| Jan. 20, 2023 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 25000 | $0.75 | 135,000.0000 | 15,327,328 | 22.73% | 0.16% |
| Dec. 29, 2022 | SHALLCROSS STEVEN A | CEO and CFO | P | Common Stock | 100000 | $0.44 | 110,000.0000 | 15,844,061 | 1000.00% | 0.63% |